Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Morales Robert

2. Date of Event Requiring Statement (MM/DD/YYYY) 3/13/2021

3. Issuer Name and Ticker or Trading Symbol

ACORDA THERAPEUTICS INC [ACOR]

(Last) (First) (Middle)

420 SAW MILL RIVER ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Interim PAO & PFO /

(Street)

ARDSLEY, NY 10502

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4872 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽²⁾	12/1/2024	Common Stock	1667	$212.88	D
Employee Stock Option (right to buy)	⁽³⁾	3/4/2025	Common Stock	35	$214.44	D
Employee Stock Option (right to buy)	⁽⁴⁾	3/2/2026	Common Stock	200	$213.18	D
Employee Stock Option (right to buy)	⁽⁵⁾	3/1/2027	Common Stock	185	$164.85	D
Employee Stock Option (right to buy)	⁽⁶⁾	4/24/2027	Common Stock	642	$96.00	D
Employee Stock Option (right to buy)	⁽⁷⁾	2/2/2028	Common Stock	334	$151.80	D
Employee Stock Option (right to buy)	⁽⁵⁾	3/1/2028	Common Stock	284	$146.10	D
Employee Stock Option (right to buy)	⁽⁸⁾	8/1/2028	Common Stock	334	$148.50	D
Employee Stock Option (right to buy)	⁽⁹⁾	3/8/2029	Common Stock	395	$81.06	D
Employee Stock Option (right to buy)	⁽¹⁰⁾	11/7/2029	Common Stock	2584	$14.46	D
Employee Stock Option (right to buy)	⁽¹¹⁾	2/16/2030	Common Stock	834	$10.74	D

Explanation of Responses:
(1)	Includes 118 unvested restricted stock awards and 3,300 unvested restricted stock unit awards issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. 59 of the restricted stock awards vest on December 1, 2021 and 59 vest on December 1, 2022, subject to continued service. The restricted stock units each represent a contingent right to one share of the Issuer's common stock, subject to continued service, vesting in installments of 40%, 20%, and 40% at 6 months, 12 months, and 18 months, respectively, after the grant date.
(2)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on December 1, 2018.
(3)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2019.
(4)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2020.
(5)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2021.
(6)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested based on achievement of specified performance milestones and were fully vested on April 2, 2018.
(7)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on February 2, 2018, with the first quarterly installment vesting on May 2, 2018.
(8)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on August 1, 2018, with the first quarterly installment vesting on November 1, 2018.
(9)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019, with the first quarterly installment vesting on April 1, 2019.
(10)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on November 7, 2019, with the first quarterly installment vesting on February 7, 2020.
(11)	Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on February 16, 2020, with the first quarterly installment vesting on May 16, 2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Morales Robert 420 SAW MILL RIVER ROAD ARDSLEY, NY 10502			Interim PAO & PFO